돌아가기
Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
HRID 203생성일: 2026년 10월 23일

1-Methylpiperazine → N-[5-(4-methylpiperazin-1-yl)pyrazin-2-yl]acetamide

https://huagongshe.com/ko/reaction/203

반응식

참여 물질

역할이름HCID투입량
반응물1-MethylpiperazineHCID 53167—
반응물N-(5-Bromopyrazin-2-YL)acetamideHCID 58574049—
시약Potassium tert-butoxideHCID 23665647—
촉매Tris(1,1-dimethylethyl)phosphineHCID 83681—
촉매Bis(dibenzylideneacetone)palladiumHCID 9811564—
용매DimethylformamideHCID 6228—
생성물N-[5-(4-methylpiperazin-1-yl)pyrazin-2-yl]acetamideHCID 5998394179.51%

반응 조건

온도120 °C

반응 단계

1-methylpiperazine (2.318 g, 23.14 mmol), N-(5-bromopyrazin-2-yl)acetamide (1 g, 4.63 mmol), tri-tert-butylphosphine (1.873 g, 9.26 mmol), tris(dibenzylideneacetone)dipalladium (0.085 g, 0.09 mmol) and potassium 2-methylpropan-2-olate (1.039 g, 9.26 mmol) were suspended in DMF (9.26 ml) and sealed into a microwave tube. The reaction was heated to 120 °C for 40 minutes in the microwave reactor and cooled to RT. The mixture was diluted with methanol and acidified with HCl, then the solution was purified by ion exchange chromatography, using an SCX column. The desired product was eluted from the column using 7M NH3/MeOH and pure fractions were evaporated to dryness to afford N-(5-(4-methylpiperazin-1-yl)pyrazin-2-yl)acetamide (0.866 g, 80 %) as a dark oil. Used without further purification.

출처 및 근거

출처 데이터셋750 AstraZeneca ELN dataset
ORD IDord-96727602adb24b28af9c737e24f7315c
출처 메모750 AstraZeneca ELN dataset